It is one of the most confusing wrinkles in the whole Roundup story. The brand is the same and the bottle looks familiar — but the Roundup sold to homeowners today is a chemically different product from the one most lawsuits are about. Bayer removed glyphosate from its U.S. consumer lawn-and-garden line, and people understandably assume that if the company “fixed” the product, the legal window closed with it. That assumption gets the timing backwards. A cancer claim looks back at what you were exposed to, not forward at what is on the shelf now — and Bayer’s own explanation for the switch tells you why the old product still matters.
The Short Answer
Yes, you can still sue over the glyphosate-based Roundup you used, even though today’s consumer version is glyphosate-free. Bayer began replacing glyphosate in U.S. residential Roundup in 2023, but a cancer claim is based on the product a person was actually exposed to over the years — not on the current formula. The company said it made the change “exclusively to manage litigation risk and not because of any safety concerns.” That is a business decision about future sales; it does not undo a single day of past exposure or alter an existing claim.
What Actually Changed in 2023
In July 2021, Bayer announced that beginning in 2023 it would replace the glyphosate in its residential lawn-and-garden Roundup products sold in the United States with different, non-glyphosate active ingredients. The reformulated consumer bottles that reach store shelves now rely on other weed-killing chemistry that was submitted for EPA review, rather than the glyphosate that made the original product famous. For the everyday buyer, the label still says “Roundup,” but the working ingredient underneath is not the same.
Two details matter more than the chemistry. First, the change applied to the consumer line — the products homeowners buy for driveways, gardens, and yards. Second, it was prospective: it governs what Bayer sells going forward, not what millions of people already sprayed for years or decades before 2023. A reformulation is not a recall, and it is not an admission that the earlier product was defective. It simply changes what is in the next bottle.
Why Bayer Really Changed the Formula
Here is the part that reframes everything. Bayer did not describe the switch as a safety upgrade. In its own words, the company said the reformulation was being made “exclusively to manage litigation risk and not because of any safety concerns,” and it pointed out that the vast majority of claims came from residential users. In other words, the consumer product was reformulated precisely because home users — the people spraying it around the yard — were the ones bringing the cancer cases.
Notice what that explanation does and does not concede. Bayer maintains that glyphosate is safe; it did not remove the ingredient because it agreed with the plaintiffs. But by moving glyphosate out of the product most likely to generate lawsuits, the company implicitly acknowledged where the legal exposure lives: with the residential users of the glyphosate-based formula. That is the exact group these cases are built around, and reformulating the future product says nothing about whether the past product caused harm.
Does the New Formula Affect a Lawsuit Over the Old One?
No — and understanding why requires separating two different things a product-liability case looks at. A claim is anchored to the specific product a person was exposed to: the glyphosate-based Roundup they bought, poured, mixed, and sprayed. The relevant facts are that person’s exposure history and diagnosis, frozen at the time the exposure happened. What Bayer chooses to put in a bottle sold in 2026 is a separate commercial fact that does not travel backward in time.
This is ordinary product-liability logic, not a Roundup-specific quirk. When a car model is redesigned after a defect surfaces, the redesign does not extinguish the claims of people injured by the earlier version. When a drug is reformulated or pulled, patients harmed by the original are not barred because the newer version is different. The product that matters is the one that caused the injury. For a Roundup claim, that is the glyphosate formula, and it is the same product whether or not the current consumer line still contains glyphosate. What actually governs whether a claim is timely is your state’s statute of limitations — the deadline that turns on your diagnosis, not on when a product was discontinued.
“But the Product I Used Is Off the Shelf Now”
A discontinued formula can feel like lost evidence, but exposure to it is proven the same way exposure to any consumer product is proven. No one keeps decades of Roundup receipts, and the law does not expect them to. The exposure record is rebuilt from the ordinary traces a life leaves behind:
- Your own account of what you bought, where, and how often you used it — on which lawn, garden, farm, or job, and over what span of years.
- Corroboration such as store loyalty or credit records, photographs of your property or work, the nature of the property itself, and product labeling from the years in question.
- Witnesses — family members, neighbors, or coworkers who saw you mix and spray it — whose testimony fixes the pattern and duration of use.
The reformulation actually sharpens the timeline rather than clouding it. Because glyphosate-based consumer Roundup was the product on the shelf through the years leading up to 2023, exposure during that period is exposure to the glyphosate formula. We walk through how this record gets assembled in how to prove Roundup exposure, and how at-home use in particular is evaluated in our guide to home and garden Roundup use.
How the Reformulation Fits the Case After Durnell
The reformulation also lands in a specific legal moment. On June 25, 2026, the U.S. Supreme Court decided Monsanto Co. v. Durnell, holding that federal pesticide law preempts state failure-to-warn claims where the EPA approved a label with no cancer warning. What survived is the design-defect claim — the argument that the glyphosate-based product itself was unreasonably dangerous, independent of anything printed on the label.
Read against that backdrop, the 2023 reformulation is quietly relevant. A design-defect case asks whether a reasonable, safer alternative design was available — a formulation that did the job with less risk. Bayer’s decision to sell a functioning consumer weedkiller without glyphosate shows that an alternative existed and was commercially viable. We do not overstate the point: Bayer frames the switch as litigation management, continues to defend glyphosate’s safety, and any design-defect argument still has to be proven with expert evidence. But a marketed, glyphosate-free version of the same product is a fact the design-defect analysis takes seriously.
Glyphosate Did Not Disappear — It Moved to the Farm
One more point corrects a common misread. Bayer did not stop making glyphosate. The 2023 change was limited to the U.S. residential line; glyphosate-based Roundup remains on the market for agricultural and professional use. Farmers, commercial applicators, landscapers, and groundskeepers may still be handling glyphosate formulations today. So glyphosate exposure did not close in 2023 — it continues among occupational users, on top of the years of residential exposure that predate the reformulation. Our coverage of landscapers and groundskeepers and of farmworkers and agricultural workers addresses those exposure groups directly.
What This Means for a Case
The threshold question does not depend on today’s formula at all. It is whether a person has a qualifying diagnosis — non-Hodgkin lymphoma and its subtypes, chronic lymphocytic leukemia, or multiple myeloma — connected to a documented history of exposure to glyphosate-based Roundup. Herb Borroto, M.D., J.D., our Medical-Legal Expert, reviews the pathology in each case personally, matching the diagnosis to the exposure history, because that pairing is what the causation science turns on. Alex Alvarez, our Managing Partner and a Board Certified Civil Trial Lawyer, has built these cases on the design-defect and strict-product-liability theory — the theory Durnell left standing, and the one to which a marketed glyphosate-free alternative is directly relevant.
If you are holding a new bottle labeled glyphosate-free and wondering whether the years you spent using the old one still count, the answer is that they do. Our overview of who qualifies for a Roundup lawsuit walks through exactly how that evaluation works.
Frequently Asked Questions
Does the new glyphosate-free Roundup mean I can no longer sue?
No. A Roundup cancer claim is based on the glyphosate-based product a person actually used and was exposed to, not on whatever formula is sold today. Bayer removed glyphosate from U.S. consumer lawn-and-garden Roundup beginning in 2023, but that change is forward-looking. It does not erase years of past exposure to the older glyphosate formula, and it does not change anyone’s existing claim.
Why did Bayer take glyphosate out of consumer Roundup?
Bayer announced in 2021 that it would replace glyphosate in U.S. residential lawn-and-garden Roundup starting in 2023. The company stated the move was being made “exclusively to manage litigation risk and not because of any safety concerns,” and noted that the vast majority of claims came from residential users. Glyphosate-based Roundup remains on the market for agricultural and professional use.
The product I used is off the shelves now. Can I still prove I used it?
Usually, yes. Exposure to a discontinued formula is proven the same way exposure to any consumer product is proven: through your own account of what you bought and how you used it, plus corroboration such as store loyalty records, photos, the type of yard or job, product labels from the relevant years, and witnesses who saw you use it. A product leaving the shelf does not erase the years you used it.
Is the reformulated Roundup safe?
The reformulated consumer products use different, non-glyphosate active ingredients, and this firm takes no position on their safety. What matters for a cancer claim is the older, glyphosate-based product. In 2015 the World Health Organization’s cancer agency (IARC) classified glyphosate as probably carcinogenic to humans, naming non-Hodgkin lymphoma as the cancer of concern. That classification is about glyphosate — the ingredient Bayer removed from the consumer line.
Bottom Line
The glyphosate-free Roundup on today’s shelf is a different product than the one at the heart of this litigation, and swapping the ingredient does not close the door on anyone’s claim. If anything, Bayer’s own reason for the change — managing litigation risk from residential users, by its own account, rather than addressing a safety problem — underscores who these cases belong to and demonstrates that a glyphosate-free version of the product was achievable. A claim looks back to the glyphosate-based Roundup a person actually used, over the years they used it. That history is unchanged by what is in the next bottle.
Nothing here is a prediction about any particular case, and past verdicts are never a promise of any future result. This article is general legal information, not advice on your own facts. If you or a family member were diagnosed with Non-Hodgkin Lymphoma, B-cell Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma after Roundup exposure, a free case review is the right next step — no obligation, and no fee unless we recover for you.